Meta-Analysis of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients Without Diabetes

被引：1
|
作者：
Mohamed, M. G. Mohamed [1 ]
Shaikh, Safia [1 ]
Osman, Mohammed [2 ]
Kheiri, Babikir [3 ]
机构：
[1] SSM Hlth St Marys Hosp, St Louis, MO USA
[2] West Virginia Univ, Sch Med, Div Cardiol, Morgantown, WV 26506 USA
[3] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2021年 / 148卷
关键词：
D O I：
10.1016/j.amjcard.2021.03.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 176
页数：2
相关论文
共 50 条
  • [31] Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis
    Li, Min
    Yi, Tieci
    Fan, Fangfang
    Qiu, Lin
    Wang, Zhi
    Weng, Haoyu
    Ma, Wei
    Zhang, Yan
    Huo, Yong
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [32] Benefit of sodium-glucose cotransporter-2 inhibitors on survival outcome is related to the type of heart failure: A meta-analysis
    Zhao, Lingyue
    Guo, Wenqin
    Huang, Weichao
    Wang, Lili
    Huang, Siquan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 187
  • [33] Meta-Analysis on the Safety and Efficacy of Sodium Glucose Cotransporters 2 Inhibitors in Patients With Heart Failure With and Without Diabetes
    Hasan, Mohammed Tarek
    Awad, Ahmed K.
    Shih, Mohamed
    Attia, Amir N.
    Aboeldahab, Heba
    Bendary, Mohamed
    Bendary, Ahmed
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 187 : 9 - 9
  • [34] Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials
    Fukuta, Hidekatsu
    Hagiwara, Hiromi
    Kamiya, Takeshi
    IJC HEART & VASCULATURE, 2022, 42
  • [35] Benefit of sodium-glucose cotransporter-2 inhibitors on survival outcome is related to the type of heart failure: A meta-analysis
    Zhao, Lingyue
    Guo, Wenqin
    Huang, Weichao
    Wang, Lili
    Huang, Siquan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 187
  • [36] Impact of sodium-glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis
    Bhalraam, U.
    Veerni, Rathna B.
    Paddock, Sophie
    Meng, James
    Piepoli, Massimo
    Lopez-Fernandez, Teresa
    Tsampasian, Vasiliki
    Vassiliou, Vassilios S.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
  • [37] Sodium-glucose cotransporter 2 inhibitors in the treatment of heart failure patients: A systematic review and meta-analysis of cost-utility studies
    Zhang, Xinyue
    Zhang, Yanxia
    Wang, Jiayu
    Tang, Zhijia
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2025, 133
  • [38] Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Acute Myocardial Infarction With or Without Type 2 Diabetes: A Systematic Review and Meta-analysis
    Zhang, Xuefang
    Sun, Gang
    Li, Zhiquan
    Gao, Weidong
    Tan, Wenfeng
    Liu, Jinxue
    Zhang, Bin
    Wu, Juan
    Chen, Rong
    Li, Xiu Juan
    Zhang, Gaoxing
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 84 (01) : 18 - 25
  • [39] Prescribing Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes-A Continuing Review
    Winters, Ashley
    Lopez, Miguel
    Ray, Gretchen
    Anderson, Joe R.
    DIABETES, 2024, 73
  • [40] Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis
    Hou, Jingjin
    Ren, Li
    Hou, Qingbin
    Jia, Xiaodong
    Mei, Zhu
    Xu, Jiaxin
    Yang, Zheming
    Li, Yiming
    Yan, Chenghui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
12345